JPMorgan analyst Mark Strouse upgraded Itron to Neutral from Underweight with a $68 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ITRI:
- These 3 stocks are Cowen’s best ideas for 2024 including AstraZeneca and Datadog
- Itron initiated with a Buy at Roth MKM
- Elastic upgraded, Alibaba downgraded: Wall Street’s top analyst calls
- Itron initiated with a Hold at Canaccord
- Itron raises FY23 EPS view to $2.83-$2.93 from $2.03-$2.28, consensus $2.20